Key Abstracts in Early Breast Cancer From ASCO 2023 Key Abstracts in Early Breast Cancer From ASCO 2023

Dr Harold Burstein highlights abstracts in early breast cancer from ASCO 2023, including the NATALEE trial of CDK4/6 inhibitor ribociclib and a meta-analysis on risk reduction with ovarian ablation.Medscape

Source: Medscape Today Headlines - June 27, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news